A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasisLin Cai, Jianzhong Zhang, Congjun Jiang et al.|British Journal of Dermatology|2024Cited by 21
Expert Consensus on the Clinical Application of Aminolevulinic Acid-Based Photodynamic Therapy for Acne Vulgaris (2022)#Leihong Xiang, Qiang Ju, Gang Wang et al.|International Journal of Dermatology and Venereology|2023Cited by 0